Assessment Of Biomarkers In Ductal Carcinoma In Situ- An Original Research
Abstract
Background: Ductal carcinoma in situ (DCIS) is defined as a lesion in which cancer cells do not grow beyond the basal membrane of the mammary duct.1 It is considered to be a predecessor of invasive ductal carcinoma (IDC). In present study, biomarkers were studied in DCIS patients.
Published
2020-05-14
How to Cite
Abhey Chawla, Parul Kalra, Prakash Chandra Jha, Priyadershini Rangari. (2020). Assessment Of Biomarkers In Ductal Carcinoma In Situ- An Original Research. International Journal of Advanced Science and Technology, 29(9s), 2623 - 2627. Retrieved from http://sersc.org/journals/index.php/IJAST/article/view/15334
Section
Articles
